A novel Trypanosoma cruzi secreted antigen as a potential biomarker of Chagas disease

Chagas drug discovery has been hampered by a lack of validated assays to establish treatment efficacy in pre-clinical animal models and in patients infected with T. cruzi. Reduced levels of parasite secreted antigens in the blood of infected hosts could be used to demonstrate treatment efficacy. A p...

Descripción completa

Detalles Bibliográficos
Autores principales: Nagarkatti, Rana, Acosta, David, Acharyya, Nirmallya, de Araujo, Fernanda Fortes, Elói-Santos, Silvana Maria, Martins-Filho, Olindo Assis, Teixeira-Carvalho, Andréa, Debrabant, Alain
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7658208/
https://www.ncbi.nlm.nih.gov/pubmed/33177582
http://dx.doi.org/10.1038/s41598-020-76508-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7658208/
https://www.ncbi.nlm.nih.gov/pubmed/33177582
http://dx.doi.org/10.1038/s41598-020-76508-1

Ejemplares similares